GSK and AZ collaborate on translational research centre
May 12, 2011Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research
The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …
SHL Continues to Expand Taiwan Facilities to Support Auto Injector Production
May 12, 2011Manufacturing and Production assembly, auto injector, autoinjector, automation, cnc, shl group
May 12, 2011 [Taoyuan, Taiwan]: SHL has just completed an additional expansion of its Nan Kan 6 facility located in …
Life appoints head of digital
May 12, 2011Medical Communications appointment, medical communications
Faisal Ahmed has joined Berkshire, UK-based comms agency Life as head of digital. Faisal’s digital pedigree includes being part of …
PCTs increasingly ‘red list’ drugs to cut costs
May 12, 2011Sales and Marketing GP prescribing deicisions, GPs, PCTs, prescribing
GPs are being asked not to prescribe NICE-approved drugs in order to cut costs. In the last year more than …
Government wrong to push for Avastin in eye disease, says charity
May 12, 2011Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD
The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …
Roche aims for wholly personalised skin cancer drug
May 12, 2011Sales and Marketing Roche, personalised medicine, skin cancer, vemurafenib
Roche has submitted its key skin cancer drug vemurafenib to European and American regulators for approval. Vemurafenib (formerly RG7204) has …
AZ signs targeted colon cancer drug collaboration
May 11, 2011Research and Development AstraZeneca, colorectal cancer, personalised medicine
AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …
Drug regulators protect profits over patients, new study finds
May 11, 2011Research and Development Bad Science, Vioxx, regulatory affairs
Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …
New product can overtake Lantus, says Novo leader
May 11, 2011Sales and Marketing Novo Nordisk, degludec, diabetes, insulin
Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …
Verdict on AMT’s gene therapy expected soon
May 11, 2011Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes
Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …
Digital Pharma: NICE puts guidance into online pathways
May 11, 2011Sales and Marketing Digital Pharma blog, NICE
NICE has launched a new online tool that groups its guidance into user-friendly flowcharts to show care pathways. NICE Pathways …
Service Insight: Clinical trials – managing route to market
May 11, 2011Research and Development Service Insight, Talking Point, research and development
SERVICE INSIGHT Clinical trials are notoriously difficult to manage and often fraught with problems, as they can involve many clinical …
Pfizer drops early-stage asthma candidate
May 11, 2011Research and Development Pfizer, Rigel, asthma
Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …
Wave Healthcare appoints former BMS medical liaison manager
May 11, 2011Medical Communications appointment, medical communications
Buckinghamshire-based med comms agency Wave Healthcare has appointed five new members of staff, including a former senior medical liaison manager …
Elan sells formulations unit to Alkermes for $960m
May 10, 2011Manufacturing and Production Alkermes, Elan
Irish drugmaker Elan has finally found a buyer for its Elan Drug Technologies unit, which has been on and off …
FDA fast-tracks Bayer’s GIST drug regorafenib
May 10, 2011Sales and Marketing Bayer, GIST, regorafenib
The assessment of Bayer HealthCare’s investigational drug regorafenib is to be fast-tracked by US authorities for the treatment of stomach …
Digital Pharma: European doctors’ communities form major alliance
May 10, 2011Medical Communications Coliquio, Digital Pharma blog, Doctors.net.uk, Egora, Medcenter, doctors' social networks, meduniverse, online doctors communities
Europe’s largest online doctors communities have formed an alliance that could help pharma break through the language barrier to engage …
Merck KGaA sells South African manufacturing unit
May 10, 2011Manufacturing and Production Merck KGaA, Merck Pharmaceutical Manufacturing, Merck South Africa
Merck South Africa, a subsidiary of Germany’s Merck KGaA, has sold its manufacturing to a local private equity firm as …
Frank Walters joins Frontera as chairman
May 10, 2011Medical Communications appointment, medical communications
Healthcare comms start-up Frontera London has appointed industry veteran Frank Walters as its non-executive chairman. Frank was previously creative director …
Generic and API firms get latest crop of FDA warning letters
May 10, 2011Manufacturing and Production Cephazone, FDA, FDA warning letter, Ningbo Smart, Teva
Generic drugmakers Teva and Cephazone and API producer Ningbo Smart are the latest companies to receive warning letters from the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
